News for Materialise NV (MTLS)

The following slide deck was published by Materialise NV in conjunction with their 2025 Q1 earnings call.

Materialise NV (NASDAQ:MTLS) Q1 2025 Earnings Conference Call April 24, 2025 8:30 AM ETCompany ParticipantsHarriet Fried - Alliance Advisors, IRBrigitte de...

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Materialise NV (NASDAQ:MTLS), a leading provider of additive manufacturing and medical software and of sophisticated 3D printing services, today announced its

ZeroHedge - On a long enough timeline, the survival rate for everyone drops to zero

Materialise NV (MTLS) will release its Q1 2025 earnings on April 24, 2025. A conference call discussing the results is scheduled for the same day at

We recently published a list of the 13 NASDAQ Stocks with the Highest Upside Potential. In this article, we are going to take a look at where Microsoft Corp.

We recently published a list of 10 Best Fundamental Stocks to Buy According to Billionaires.

Palantir’s FY24 growth includes a 72.9% rise in US commercial customers. Find out why PLTR stock’s forecasted 30.8% growth in FY25 is a key indicator for investors.

Tesla faces near-term challenges in orders, which could impact its FY25 performance. Click here to read why we rate TSLA stock a conditional Hold.

Palantir's stock has seen a significant reversal, dropping 35% from its peak, despite AI momentum. See why we strongly advise against buying the dip in PLTR.

Plus, Perella Weinberg’s decade-long legal fight finally nears its end and Britain’s biggest grocers waver under private equity

Alphabet's accelerated AI rollouts, particularly Gemini 2.0, are expected to boost search engagement and ad revenue. See why we reiterate Buy for GOOGL stock.

Apple's revolutionary iPhone 16e delivers substantial upgrades over SE 3, featuring the crucial A18 chip. Read why we're cautiously optimistic on AAPL stock.

**media[549385]**

Materialise reports weak Q4 earnings but strong performance in key segments. Learn why MTLS stock’s current valuation is supported by Medical and Software.

**media[546373]**

U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 1% on Thursday. The Dow traded down 1.11% to 44,132.13 while the...

Discover Materialise NV's Q4 2024 Earnings Insights: 4% growth despite challenges, robust Medical & Software performance, and 2025 outlook.